Discovery of a neutralizing antibody to treat covid-19
THE NEEDA number of therapeutic options have been explored over the course of the COVID-19 pandemic, yet there is still no effective treatment for hospitalized patients. It istherefore crucial to identify targets for antiviral intervention and elucidate critical viraland host determinants that play a central role in the development of severe disease. THE SOLUTIONFast track […]
Discovery of a therapeutic antibody for the treatment of inflammatory bowel disease and type I diabetes
THE NEEDPreventing apoptopic cell loss in IBD and insulin-dependent diabetes patientsInsulin-like growth factor binding-protein 3 (IGFBP3) binds to Transmembrane Receptor 219 (TMEM219) on intestinal stem cells (ISCs) and pancreatic beta cells and mediates cell death/apoptosis in an IGF1-independent way. Dysregulation of the IGFBP3/TMEM219 axis, due to increased levels of circulating free IGFBP3, plays a key role […]
15.12. – 19.12.2024 | AB Engineering & Therapeutics
USA, San Diego
18.11. – 19.11.2024 | Antibody Therapeutics and Immuno-Oncology EU Hub Xchange
Belgium, Brussels
05.11. – 07.11.2024 | PEGS Europe
Spain, Barcelona
04.11. – 06.11.2024 | BIO Europe
Sweden, Stockholm
15.10. – 17.10.2024 | Festival of the Biologics EU
Switzerland, Basel
09.10. – 11.10.2024 | BIO Japan
Japan, Yokohama
09.10.2024 | BioRN Annual Conference
Germany, Heidelberg
17.09. – 19.09.2024 | Nordic Life Science Days
Sweden, Malmö
